###begin article-title 0
EWS/ETS Regulates the Expression of the Dickkopf Family in Ewing Family Tumor Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: YM HO NK. Performed the experiments: YM MI. Analyzed the data: YM. Contributed reagents/materials/analysis tools: YM MT YUK JF JiH AU. Wrote the paper: YM HO NK.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The Dickkopf (DKK) family comprises a set of proteins that function as regulators of Wnt/beta-catenin signaling and has a crucial role in development. Recent studies have revealed the involvement of this family in tumorigenesis, however their role in tumorigenesis is still remained unclear.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 558 563 <span type="species:ncbi:9606">human</span>
###xml 904 908 <span type="species:ncbi:10090">mice</span>
We found increased expression of DKK2 but decreased expression of DKK1 in Ewing family tumor (EFT) cells. We showed that EFT-specific EWS/ETS fusion proteins enhance the DKK2 promoter activity, but not DKK1 promoter activity, via ets binding sites (EBSs) in the 5' upstream region. EWS/ETS-mediated transactivation of the promoter was suppressed by the deletion and mutation of EBSs located upstream of the DKK2 gene. Interestingly, the inducible expression of EWS/ETS resulted in the strong induction of DKK2 expression and inhibition of DKK1 expression in human primary mesenchymal progenitor cells that are thought to be a candidate of cell origin of EFT. In addition, using an EFT cell line SK-ES1 cells, we also demonstrated that the expression of DKK1 and DKK2 is mutually exclusive, and the ectopic expression of DKK1, but not DKK2, resulted in the suppression of tumor growth in immuno-deficient mice.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Our results suggested that DKK2 could not functionally substitute for DKK1 tumor-suppressive effect in EFT. Given the mutually exclusive expression of DKK1 and DKK2, EWS/ETS regulates the transcription of the DKK family, and the EWS/ETS-mediated DKK2 up-regulation could affect the tumorigenicity of EFT in an indirect manner.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 260 263 254 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Mohinta1">[1]</xref>
###xml 265 268 259 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Reguart1">[2]</xref>
###xml 270 273 264 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Segditsas1">[3]</xref>
###xml 594 597 585 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Polakis1">[4]</xref>
###xml 627 630 618 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Satoh1">[5]</xref>
###xml 344 349 <span type="species:ncbi:9606">human</span>
The Wnt/beta-catenin signaling pathway is known to regulate development, differentiation, and a variety of biological phenomena. Recent findings support notion that the aberration of canonical Wnt/beta-catenin signaling is involved in malignant transformation [1], [2], [3]. Mutations in components of the pathway have been observed in primary human cancers. These mutations often allow ligand-independent Wnt/beta-catenin signaling in tumor cells. Among the components, the tumor suppressor Adenomatous polyposis coli (APC) and the scaffold protein Axin are frequently mutated in colon cancer [4] and hepatocellular carcinoma [5] respectively. Mutations in beta-catenin itself are also found in a number of cancers. These changes induce the stabilization of beta-catenin in the cytoplasm and an abnormal accumulation of free beta-catenin in the nucleus, resulting in the aberrant activation of Wnt target genes through T-cell factor family members.
###end p 9
###begin p 10
###xml 216 219 210 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Kawano1">[6]</xref>
###xml 221 224 215 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Zorn1">[7]</xref>
###xml 663 666 651 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Brott1">[8]</xref>
###xml 668 671 656 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Mao1">[9]</xref>
###xml 771 775 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Mukhopadhyay1">[10]</xref>
###xml 777 781 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Grotewold1">[11]</xref>
###xml 783 787 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Adamska1">[12]</xref>
###xml 807 811 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Morvan1">[13]</xref>
###xml 813 817 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Li1">[14]</xref>
###xml 229 234 <span type="species:ncbi:9606">human</span>
A number of activators and antagonists in the Wnt/beta-catenin signaling pathway have been cloned and investigated. The Dickkopf (DKK) family is comprised of secreted protein modulators of Wnt/beta-catenin signaling [6], [7]. In human, the family consists of DKK1, DKK2, DKK3/REIC and DKK4, all of which have two cysteine-rich domains. DKK1 interacts with low-density lipoprotein receptor (LRP) 5/6, a component of the Wnt receptor complex, and inhibits canonical Wnt/beta-catenin signaling (Mao et al. 2001). DKK2 is structurally very similar to DKK1 and also interacts with LRP5/6, but its effect on Wnt/beta-catenin signaling is thought to be rather agonistic [8], [9]. DKKs have been found to be important in multiple developmental processes such as limb development [10], [11], [12] and bone formation [13], [14].
###end p 10
###begin p 11
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Niehrs1">[15]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Aguilera1">[16]</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Kuphal1">[17]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Mikheev1">[18]</xref>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Mikheev2">[19]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Mikheev3">[20]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Tian1">[21]</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Wirths1">[22]</xref>
###xml 782 786 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Edamura1">[23]</xref>
###xml 797 801 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Kuphal1">[17]</xref>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Hsieh1">[24]</xref>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Hoang1">[25]</xref>
###xml 902 906 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Tsuji1">[26]</xref>
###xml 922 926 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Tsuji1">[26]</xref>
###xml 947 951 947 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Lodygin1">[27]</xref>
In addition, it has been recently reported that DKKs play a crucial role in cell transformation [15]. Hyper-methylation of the promoter and gene silencing of DKK1 were observed in tumor cells, including colorectal cancer [16] and malignant melanoma cells [17]. Given evidence that ectopic expression of DKK1 suppresses features of transformation in tumor cells [18], [19], [20], DKK1 might inhibit tumorigenicity. However, the expression of DKK1 is elevated in some tumor cells including myeloma cells [21], hepatoblastoma cells and Wilm's tumor cells [22]. Therefore, the molecular function of DKK1 in cancer is controversial and still not fully elucidated. DKK3/REIC is also proposed as a tumor suppressor. The overexpression of DKK3/REIC inhibits tumor growth in prostate cancer [23], melanoma [17] and hepatocellular carcinoma [24]. The down-regulated expression of DKK3/REIC in osteosarcoma [25], [26], hepatoblastma [26] and prostate cancer [27] further supports this notion. Although these studies indicate that the modulation of DKK expression contributes to tumorigenicity, the underlying molecular mechanism is not fully understood.
###end p 11
###begin p 12
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Khoury1">[28]</xref>
###xml 570 574 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Fuchs1">[29]</xref>
###xml 585 589 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Li2">[30]</xref>
###xml 599 603 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Takahashi1">[31]</xref>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Nakatani1">[32]</xref>
###xml 730 734 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Hahm1">[33]</xref>
###xml 736 740 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Im1">[34]</xref>
###xml 328 331 <span type="species:ncbi:12672?0.125">FEV</span>
Ewing family tumor (EFT) is a pediatric cancer arising from bone and soft tissues. In EFT, a specific translocation results in production of the fusion protein EWS/ETS, where the C-terminal of EWS, including the RNA-binding domain, is replaced with a DNA-binding domain of the ets gene family, such as FLI1, ERG, E1AF, ETV1 and FEV [28]. The consequent fusion proteins have been proposed to act as an aberrant transcriptional regulator and believed to play an important role in the initiation and development of EFT. EWS/FLI1, transactivates the expression of cyclin D1 [29], cyclin E [30] and TERT [31] through the Sp1, E2F or ets DNA-binding sites located in each promoter, but suppresses the expression of p21 [32] and TGFBRII [33], [34].
###end p 12
###begin p 13
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Miyagawa1">[35]</xref>
###xml 178 183 <span type="species:ncbi:9606">human</span>
In this paper, we present evidence of enhanced DKK2 but suppressed expression of DKK1 in EFT cells. The experiments including those using inducible EWS/ETS expression systems in human primary bone marrow-derived mesenchymal progenitor cells (hMPCs) [35] demonstrated that the expression of DKKs is regulated by the EFT-specific chimeric protein, EWS/ETS. We further address the role of DKKs in the tumorigenicity of EFT.
###end p 13
###begin title 14
Materials and Methods
###end title 14
###begin title 15
Animals
###end title 15
###begin p 16
###xml 139 144 <span type="species:ncbi:9606">Child</span>
All the animals used in this study were treated in accordance with regulation on Animal Experimentation at National Research Institute for Child Health and Development.
###end p 16
###begin title 17
Plasmid construction
###end title 17
###begin p 18
###xml 206 210 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoR</italic>
###xml 452 455 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 484 487 476 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 519 522 507 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sac</italic>
###xml 794 831 782 819 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTACCTTAAA GAAACCTTAT TCAAAAGATA3&#8242;</named-content>
###xml 836 874 824 862 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGATTTTTCA CATTTTAGTG TGTGGGGTTT-3&#8242;</named-content>
###xml 961 999 949 987 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCACCTTGCC AAGGAAGACA GGATCTCAAA-3&#8242;</named-content>
###xml 1004 1042 992 1030 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTTCTAGCCC CAGTGAATTA CAAGAGAAGC-3&#8242;</named-content>
###xml 1103 1107 1091 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Yamashita1">[36]</xref>
###xml 1153 1157 1141 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoR</italic>
###xml 1328 1332 1307 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Hara1">[37]</xref>
###xml 1339 1343 1318 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Fujii1">[38]</xref>
###xml 1362 1366 1341 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Hara1">[37]</xref>
###xml 1409 1412 1388 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xmn</italic>
###xml 1414 1418 1393 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoR</italic>
###xml 157 162 <span type="species:ncbi:9606">human</span>
###xml 1692 1697 <span type="species:ncbi:9606">human</span>
To construct a luciferase reporter vector using the 5'upstream region of the DKK2 gene, the -1955/+49 genomic fragment of the gene was amplified by PCR from human lymphocyte genomic DNA and cloned into the EcoRV site of the reporter vector pGL4 (Promega) to generate pGL4-DKK2. Serial deletions of pGL4-DKK2 were generated by digestion with restriction enzymes and subsequent self-ligation. The resultant reporter vectors were designated pGL4-DKK2DeltaKpnI (-1741/+49), pGL4-DKK2DeltaNheI (-1241/+49) and pGL4-DKK2DeltaSacI (-521/+49). Mutagenesis of putative ets binding sites (EBS) in the DKK2 5'upstream region was performed using KOD-plus (TOYOBO). The primers used for the mutagenesis were as follows: for the -1585/-1573 genomic fragment of the DKK2 5'upstream region (designated EBS-1): 5'-CTACCTTAAA GAAACCTTAT TCAAAAGATA3' and 5'-AGATTTTTCA CATTTTAGTG TGTGGGGTTT-3'; for the -904/-895 genomic fragment of the DKK2 5'upstream region (designated EBS-2): 5'-GCACCTTGCC AAGGAAGACA GGATCTCAAA-3' and 5'-CTTCTAGCCC CAGTGAATTA CAAGAGAAGC-3'. A flag-tag and a Gateway cassette were amplified from pifw [36] by PCR and the product was inserted into the EcoRV site of pcDNAtrade mark3 (Invitrogen) (termed pcDNA3-flagDEST). Full-length EWS/FLI1 type II, EWS/ERG and EWS/E1AF cDNAs were amplified from cDNAs prepared from NCR-EW2 [37], W-ES [38] and NCR-EW3 cells [37], respectively, by PCR and cloned into the XmnI-EcoRV sites of pENTRtrade mark11 (Invitrogen). The resulting pENTR11-EWS/ETSs were recombined with pcDNA3-flagDEST using the LR recombination reaction as instructed by the manufacturer (Invitrogen) to construct the flag-tagged EWS/ETS expression vector pcDNA3-flagEWS/ETSs. The human DKK1 and DKK2 cDNAs without a stopcodon were subcloned into pENTRtrade mark11 and the resulting pENTR11-DKK1 and pENTR11-DKK2 were recombined with pcDNA-DEST40 C-terminally V5-His-tagged (Invitrogen) using the LR recombination reaction as instructed by the manufacturer, to obtain pcDNA-DEST40-DKK1 and -DKK2.
###end p 18
###begin title 19
Cell cultures
###end title 19
###begin p 20
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Mori1">[39]</xref>
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Miyagawa1">[35]</xref>
###xml 307 308 301 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 531 535 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Miyagawa1">[35]</xref>
###xml 567 571 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Gilbert1">[40]</xref>
###xml 590 594 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Nishi1">[41]</xref>
###xml 851 855 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Hata1">[42]</xref>
###xml 214 220 <span type="species:ncbi:9913">Bovine</span>
H4-1 (primary hMPCs), UEET-12, UET-13 (hMPCs with an extended life span through retroviral transduction) [39] and UET-13 transfectants [35] were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% Fetal Bovine Serum (FBS) or Tet System Approved FBS (Takara) at 37degreesC under a humidified 5% CO2 atmosphere. The EFT cell lines EES-1, SCCH196, RD-ES, SK-ES1, NCR-EW2, NCR-EW3 and W-ES, neuroblastoma (NB) cell lines NB9, NB69 and GOTO, and Rhabdomyosarcoma (RMS) cell line NRS-1 were maintained as described previously [35]. Other NB cell lines NB1, NB19 [40], CHP134 and IMR32 [41], the Burkitt lymphoma (BL) cell lines BJAB, Ramos, Daudi, P3HR1 and Raji (obtained from Japanese Collection of Research Bioresources, JCRB, Osaka, Japan) were cultured in RPMI 1640 medium with 10% FBS. Embryonal carcinoma (EC) cell lines NCR-G2 and NCR-G3 [42] were cultured in a 1:1 mixture of DMEM and Ham's F12 medium with 10% FBS.
###end p 20
###begin p 21
HEK293 cells were cultured in DMEM with 10% FBS. Stable transfection of HEK293 cells with pcDNA3-flagDEST or pcDNA3-flagEWS/FLI1 was performed using Lipofectaminetrade mark 2000 (Invitrogen) according to the manufacturer's directions. Individual resistant clones were selected in the presence of 1000 microg/ml of G418 for a month and designated as HEK-DEST and HEK-EWS/FLI1 cells.
###end p 21
###begin p 22
For the generation of SK-ES1 transfectants with DKK1 and DKK2, SK-ES1 cells transfected with pcDNA-DEST40-DKK1 and -DKK2, respectively and selected as described above. The consequent stable transfectants were designated SK-ES1-DKK1 and -DKK2, respectively. As a negative control, SK-ES1 cells were also transfected with empty vector pcDNA-DEST40 and designated as SK-ES1-DEST.
###end p 22
###begin title 23
Western blot analysis
###end title 23
###begin p 24
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Miyagawa2">[43]</xref>
###xml 445 451 <span type="species:ncbi:9986">rabbit</span>
###xml 460 465 <span type="species:ncbi:10090">mouse</span>
The Western blot analysis was performed as described [43]. Briefly, cell lysate was prepared, separated on a 10% SDS-PAGE gel, and transferred onto a PVDF membrane. After blocking with 5% skim milk in PBS containing 0.01% Tween-20 (Sigma) (PBST), the membrane was incubated with appropriate primary and secondary antibodies. As the primary antibody, anti-flag M2 (Sigma), anti-V5 (Invitrogen) or anti-Actin (Sigma) was used. HRP-conjugated anti-rabbit or anti-mouse IgG antibody (DakoCytomation) was used as the secondary antibody. Blots were detected using an ECL Plus Western Blotting Detection System (GE Healthcare Bio-Science Corp) and exposed to X-ray film (Kodak) for 5-30 minutes. Secreted DKK2 was detected using anti-DKK2 antibody (Biovision). For the detection of secreted DKKs-V5 proteins, 20 ml of each cell culture supernatant in SK-ES1 transfectants was collected and added to BD TALON Metal Affinity Resin (Clontech). After incubation overnight, the supernatant was removed. The resin-protein complex was purified and analyzed by Western blotting as described above.
###end p 24
###begin title 25
Immunoprecipitation (IP)
###end title 25
###begin p 26
###xml 41 45 41 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Kiyokawa1">[44]</xref>
IP was performed as described previously [44]. Whole cell extracts were incubated with anti-flag M2 antibody (Sigma) and the protein-antibody complex was bound to protein G-Dynal beads (Invitrogen). The bound complexes were washed and collected by centrifugation and separated by SDS-PAGE.
###end p 26
###begin title 27
Reporter assay
###end title 27
###begin p 28
###xml 457 463 445 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
HEK293 cells were transiently transfected with a mixture of 100 ng of pGL4 or the pGL4-DKK2 reporter vector series and 300 ng of pcDNA3-flagDEST or pcDNA3-flagEWS/ETS using Lipofectaminetrade mark 2000 (Invitrogen). The cells were also transfected with 25 ng of pcDNA/GW-40/LacZ (Invitrogen) for the standardization of transfection efficiency. The luciferase activity and beta-gal activity were measured 48 h after the transfection as described before (Mon et al., 2003).
###end p 28
###begin title 29
RT-PCR analysis
###end title 29
###begin p 30
###xml 43 47 43 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Miyagawa1">[35]</xref>
###xml 293 332 293 332 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGCTAGTCCC ACCCGCGGAG GGGACGCAGG -3&#8242;</named-content>
###xml 337 376 337 376 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTTCTTTCA GGACAGGTTT ACAGATCTTG -3&#8242;</named-content>
###xml 392 431 392 431 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAAGCGCTGC CACCGAGATG GCATGTGCTG -3&#8242;</named-content>
###xml 436 475 436 475 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GATGATCGTA GGCAGGGGTC TCCTTCATGC -3&#8242;</named-content>
###xml 583 618 583 618 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACGCGTAGAATCGAGACCGAGAGAGGGTT-3&#8242;</named-content>
###xml 722 754 722 754 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCACCCATGG CAAATTCCAT GGCA-3&#8242;</named-content>
###xml 773 805 773 805 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCTAGACGGC AGGTCAGGT CCACC-3&#8242;</named-content>
###xml 624 629 <span type="species:ncbi:9606">human</span>
RT-PCR analysis was performed as described [35]. Total RNA was extracted from cells using a RNeasy kit (QIAGEN) and reverse transcribed using a First-Strand cDNA Synthesis Kit (GE Healthcare Bio-Science Corp). The primers used for the detection of DKK1 and DKK2 were as follows: DKK1 primers, 5'-CGCTAGTCCC ACCCGCGGAG GGGACGCAGG -3' and 5'-CCTTCTTTCA GGACAGGTTT ACAGATCTTG -3'; DKK2 primers, 5'-GAAGCGCTGC CACCGAGATG GCATGTGCTG -3' and 5'-GATGATCGTA GGCAGGGGTC TCCTTCATGC -3'). For the detection of DKK-V5 fusion transcripts, the following V5-specific primer was used: V5 (reverse): 5'-ACGCGTAGAATCGAGACCGAGAGAGGGTT-3'. The human GAPDH gene was detected as an internal control with the following primers: GAPDH (forward): 5'-CCACCCATGG CAAATTCCAT GGCA-3', GAPDH (reverse): 5'-TCTAGACGGC AGGTCAGGT CCACC-3'. PCR products were electrophoresed with a 1% agarose gel and stained by ethidium bromide.
###end p 30
###begin title 31
Real-time RT-PCR analysis
###end title 31
###begin p 32
###xml 281 286 <span type="species:ncbi:9606">human</span>
Real-time RT-PCR was performed using SYBR(R) Green PCR Master Mix, TaqMan(R) Universal PCR Master Mix and TaqMan(R) Gene Expression Assays, Inventoried assay on an ABI PRISM(R) 7900HT Sequence Detection System (Applied Biosystems) according to the manufacturer's instructions. The human GAPDH gene was used as an internal control for normalization.
###end p 32
###begin title 33
Subcutaneous tumorigenicity assay
###end title 33
###begin p 34
###xml 237 238 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">Mice</span>
###xml 339 343 <span type="species:ncbi:10090">Mice</span>
Immuno-deficient mice (CB17-SCID 8 weeks old, Clea Japan, Inc) were maintained under pathogen-free conditions. SK-ES1 transfectants were suspended in 100 microl of PBS and injected s.c. into mice. Cells were injected at a density of 1x107 cells per body. Mice were monitored weekly and tumor diameter was measured with precision calipers. Mice were sacrificed after 28 days of monitoring.
###end p 34
###begin title 35
Chromatin immunoprecipitation (ChIP) assay
###end title 35
###begin p 36
###xml 1622 1649 1610 1637 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCAGGAAGCC AAGGAAGACA-3&#8242;</named-content>
###xml 1654 1685 1642 1673 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGAATAGGA AATCCCAGAT AGG-3&#8242;</named-content>
###xml 187 192 <span type="species:ncbi:10090">mouse</span>
###xml 1181 1186 <span type="species:ncbi:10090">mouse</span>
For preparing the antibody- protein G-Dynal beads (Invitrogen) complex, protein G-Dynal beads were washed with 0.5% BSA in PBS, and anti-flag antibody, anti-FLI1 antibody (Santa cruz) or mouse IgG was added. The beads mixtures were incubated and rotated overnight at 4degreesC. HEK-EWS/FLI1 cells or SK-ES1 cells were cross-linked by 1% formaldehyde for 10 minutes at room temperature. The medium was aspirated and the cells were lysed using cell lysis buffer A [50 mM HEPES pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton X-100, and Complete protease inhibitor cocktail (Roche)]. The cells were pelleted and resuspended in cell lysis buffer B [10 mM Tris-HCl pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, and Complete protease inhibitor cocktail]. Nuclei were then pelleted and lysed with cell lysis buffer C [10 mM Tris-Hcl pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% deoxycholate, 0.5% N-lauroylsarcosine, Complete protease inhibitor cocktail] on ice. The nuclear lysates were sonicated and then precleared with salmon sperm DNA/ protein G-Dynal beads for 3 hours. The cleared supernatant was incubated with anti-flag antibody, anti-FLI1 antibody or mouse IgG- protein G-Dynal beads complex. Sixteen hours after the incubation, the immune complexes were collected with centrifugation and washed 7 times using RIPA buffer [50 mM HEPES pH 7.5, 500 mM LiCl, 1 mM EDTA, 1% NP-40, 0.7% N-lauroylsarcosine, and Complete protease inhibitor cocktail]. The DNA-protein cross-linking was reversed by heating at 65degreesC. The chromatin was purified and analyzed by PCR using specific primers (EBS-2: 5'-GCAGGAAGCC AAGGAAGACA-3' and 5'-GCGAATAGGA AATCCCAGAT AGG-3'). PCR products were electrophoresed with a 2% agarose gel and stained by SYBR(R) Green I (Takara).
###end p 36
###begin title 37
Results
###end title 37
###begin title 38
Increased DKK2 and suppressed DKK1 expression in EFT cells
###end title 38
###begin p 39
###xml 158 166 <span type="species:ncbi:9606">children</span>
To identify the specific genes related to EFT cells, DNA microarray-based global expression profiling was done using EFT cell lines and other tumors found in children. By comparing the expression patterns, genes were identified as typically up-regulated in EFT cells and other cells (data not shown). Among these genes, we particularly focused on DKK2 (up-regulated) and DKK1 (down-regulated) because they are members of the DKK family and structurally well related, but revealed opposite expression patterns in EFT cells. Similar results were obtained from the microarray assay using EFT and NB tissue samples in the Gene Expression Omnibus database GEO (Accession number: GSE1825) (data not shown).
###end p 39
###begin p 40
###xml 194 201 194 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g001">Fig. 1A</xref>
###xml 355 362 355 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g001">Fig. 1B</xref>
We first confirmed the expression pattern of DKK genes obtained with the microarray assay by conducting a Real-time RT-PCR analysis. The increased expression of DKK2 was confirmed in EFT cells (Fig. 1A). DKK2 expression was especially increased in NCR-EW3 cells that express EWS/E1AF. In contrast, the expression of DKK1 was suppressed in most EFT cells (Fig. 1B).
###end p 40
###begin title 41
The expression pattern of the DKK family in Ewing's family tumor (EFT).
###end title 41
###begin p 42
###xml 406 411 <span type="species:ncbi:9606">human</span>
A, B, Real-time RT-PCR analysis using pediatric tumor cell lines for DKK1 (A) and DKK2 (B) expression. EFT: Ewing's family tumor, NB: neuroblastoma, BL: Burkitt lymphoma, RMS: Rhabdomyosarcoma, EC: embryonal carcinoma. Data are normalized to the mRNA level in SCCH196 (for DKK1) and Ramos (for DKK2) which is arbitrarily set to 1. Signal intensity was normalized using that of a control housekeeping gene (human GAPDH gene). Data are relative values with the SD for triplicate wells.
###end p 42
###begin title 43
Direct regulation of DKK2, but not DKK1, promoter activity by EWS/ETS proteins
###end title 43
###begin p 44
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Arvand1">[45]</xref>
###xml 595 602 595 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g002">Fig. 2A</xref>
###xml 745 758 745 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g002">Fig. 2B and C</xref>
###xml 1167 1170 1151 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 1185 1188 1165 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 1270 1279 1238 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g002">Fig. 2D&#8211;F</xref>
###xml 1314 1317 1278 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sac</italic>
###xml 1352 1359 1316 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g002">Fig. 2G</xref>
Previous reports revealed that EWS/ETS proteins enhance the promoter activity of several genes via the ets DNA-binding sites on the promoters [45]. A sequence analysis and TF search () revealed the 5' upstream region (-1955 to +49) of the DKK2 gene to have two putative EBSs, here designated EBS-1 (-1585 to -1573) and EBS-2 (-904 to -895). Although, the TF search did not recognize it, we also found a putative EBS (GGAA/T) element, designated as EBS-3 (-140 to -131). Thus, we next isolated the 5' upstream region of the DKK2 gene and cloned it into the reporter plasmid pGL4 (DKK2 full-Luc) (Fig. 2A) to test the effects of EWS/ETS expression on DKK2 promoter activity with transient transfection reporter assays in HEK293 cells. As shown in Fig. 2B and C, co-transfection of EWS/ETS with pGL4-DKK2 resulted in an enhancement of reporter activity approximately10-fold compared with co-transfection with empty expression vector. To map the site in the DKK2 5' upstream region required for activation by EWS/ETS expression, reporter assays using a deletion series of pGL4-DKK2 were performed. Co-transfection of the EWS/ETS expression vector with DKK2 pGL4-DKK2DeltaKpnI or -DKK2DeltaNheI resulted in a strong induction of the reporter activity (approximately15-fold) (Fig. 2D-F), whereas that with pGL4-DKK2DeltaSacI led to only a faint enhancement (Fig. 2G), indicating that the sequence from -521 to +49 in the DKK2 gene is not sufficient for EWS/ETS-mediated enhancement of DKK2 transcription.
###end p 44
###begin title 45
The effect of EWS/ETS expression on the activity of the DKK2 promoter.
###end title 45
###begin p 46
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 190 193 190 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sac</italic>
###xml 286 307 286 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 1017 1038 1014 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 1260 1281 1257 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 1763 1784 1757 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
A, Schematic representation of the 5'upstream region of the DKK2 gene. The nucleotide numbering represents the distance from the translation start site (+1). KpnI (-1741), NheI (-1241), and SacI (-521) sites were used to construct a series of deletion mutants of the DKK2 promoter (see Materials and Methods). Consensus ets binding sites are boxed (EBS-1, EBS-2 and EBS-3). B, Western blot analysis for EWS/ETS expression. HEK293 cells were transiently transfected with pcDNA3-flagDEST or pcDNA3-flagEWS/ETS and then analyzed by anti-flag Western blotting. C, The effect of EWS/ETS expression on the activity of the DKK2 promoter. HEK293 cells were co-transfected with reporter plasmids and the expression vector. Luciferase activity was measured after 48 hours. Data are relative values with the SD for triplicate wells. Data are normalized to the value for the empty vector (pcDNA3-flagDEST) which is arbitrarily set to 1. The transfection efficiency was normalized relative to the beta-galactosidase activity (See Materials and Methods). D, Schematic representation of a series of deletion mutants of the DKK2 5' upstream region. KpnI (-1741), NheI (-1241) and SacI (-521) sites were used to construct a series of deletion mutants of the DKK2 promoter (see Materials and Methods). E, F, G, The transactivation of deletion mutants of the DKK2 promoter by EWS/ETS expression. HEK293 cells were co-transfected with reporter plasmids and the expression vector. Data are normalized to the value for the empty vector (pcDNA3-flagDEST) which is arbitrarily set to 1. Luciferase activity was measured after 48 hours. Data are relative values with the SD for triplicate wells. The transfection efficiency was normalized relative to the beta-galactosidase activity (See Materials and Methods).
###end p 46
###begin p 47
###xml 180 194 180 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g003">Fig. 3A and 3B</xref>
###xml 298 301 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 424 431 420 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g003">Fig. 3B</xref>
###xml 546 549 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 556 566 548 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g003">Fig. 3A, C</xref>
To determine whether the EBSs are involved in the EWS/ETS-induced transactivation of the DKK2 promoter activity, effects of mutagenesis of EBS-1 and EBS-2 were tested. As shown in Fig. 3A and 3B, the mutation of EBS-1 suppressed the EWS/ETS-induced enhancement of the reporter activity of DKK2DeltaKpnI. When both EBS-1 and EBS-2 were simultaneously mutated, the suppressive effect against EWS/ETS was further strengthened (Fig. 3B). Likewise, the mutation of EBS-2 suppressed the EWS/ETS-induced activation of the reporter activity of DKK2 DeltaNheI-Luc (Fig. 3A, C).
###end p 47
###begin title 48
Mutational analysis of EBS in the DKK2 promoter.
###end title 48
###begin p 49
###xml 590 611 587 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
A, The substitutions in EBS-1 and EBS-2. The underlined sequences indicate the mutated sequences in EBS. B, C, The suppression of EWS/ETS-mediated activation of the DKK2 promoter by the mutations. HEK293 cells were co-transfected with mutated reporter plasmids and the expression vector. Luciferase activity was measured after 48 hours. Data are relative values with the SD for triplicate wells. Data are normalized to the value for the empty vector (pcDNA3-flagDEST) that is arbitrarily set to 1. The transfection efficiency was normalized relative to the beta-galactosidase activity (See Materials and Methods).
###end p 49
###begin p 50
###xml 306 313 306 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g004">Fig. 4A</xref>
###xml 447 454 447 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g004">Fig. 4B</xref>
###xml 527 534 527 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g004">Fig. 4C</xref>
###xml 635 642 635 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g004">Fig. 4C</xref>
###xml 723 730 723 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g004">Fig. 4D</xref>
We next evaluated the direct binding of EWS/ETS proteins to the EBSs in the DKK2 5' upstream region. In this assay, HEK293 cells were stably transfected with pcDNA-flagDEST and pcDNA-flagEWS/FLI1, respectively. The overexpression of flag-tagged EWS/FLI1 protein was confirmed in the IP-western blot assay (Fig. 4A). DKK2 expression was significantly up-regulated in HEK-EWS/FLI1 transfectants, approximately 10 fold, compared with HEK-DEST cells (Fig. 4B). When the ChIP assay was performed using these cells as illustrated in Fig. 4C (upper figure), we found that EWS/FLI1 preferentially bound to EBS-2 in HEK-EWS/FLI1 transfectants (Fig. 4C). Similarly, we also demonstrated that EWS/FLI1 bound to EBS-2 in SK-ES1 cells (Fig. 4D).
###end p 50
###begin title 51
Direct binding of EWS/FLI1 to EBS of the DKK2 promoter.
###end title 51
###begin p 52
###xml 693 700 693 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 748 769 748 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 519 524 <span type="species:ncbi:9606">human</span>
###xml 898 903 <span type="species:ncbi:10090">mouse</span>
###xml 1065 1071 <span type="species:ncbi:9986">rabbit</span>
A, Immunoprecipitation (IP) and Western blot analysis of HEK293 cells stably transfected with pcDNA3-flagDEST (HEK-DEST) or pcDNA3-flagEWS/FLI1 (HEK-EWS/FLI1). Cells were lysed and Immunoprecipitated by anti-flag antibodies. The IP products were analyzed by Westen blot analysis. B, Real-time RT-PCR analysis using HEK293 transfectants for DKK2 expression. Data are normalized to the mRNA level in HEK-DEST cells which is arbitrarily set to 1. Signal intensity was normalized using that of a control housekeeping gene (human GAPDH gene). Data are relative values with the SD for triplicate wells. DEST: HEK-DEST cells; FLI1: HEK-EWS/FLI1. C, D, Binding of EWS/FLI1 to EBS of the DKK2 promoter in vivo. The ChIP analysis was done as described under Materials and Methods. For the ChIP analysis using HEK293 transfectants, soluble chromatin was immunoprecipitated with anti-flag antibodies or normal mouse immunoglobulin (IgG) and analyzed by PCR. For the ChIP analysis using SK-ES1 cells, soluble chromatin was immunoprecipitated with anti-FLI1 antibodies or normal rabbit immunoglobulin (IgG) and analyzed by PCR. The upper figure indicates a schematic representation of the site of the DKK2 promoter detected in the ChIP analysis. Arrows indicate the position of the specific primer used for ChIP.
###end p 52
###begin p 53
We also examined the effects of EWS/ETS expression on DKK1 promoter activity. Although we also isolated the 5' upstream region of the DKK1 gene (-2108/+80) and conducted reporter assays as for the DKK2 gene, no significant enhancement of DKK1 promoter activity mediated by EWS/ETS expression was observed (data not shown).
###end p 53
###begin title 54
###xml 53 58 <span type="species:ncbi:9606">human</span>
Alteration of DKK1 and DKK2 expression by EWS/ETS in human MPCs
###end title 54
###begin p 55
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Gregory1">[46]</xref>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Gregory2">[47]</xref>
###xml 193 200 193 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g005">Fig. 5A</xref>
###xml 384 391 384 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g005">Fig. 5B</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Miyagawa1">[35]</xref>
###xml 673 682 673 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g005">Fig. 5C&#8211;F</xref>
Although the origin of EFT is still unknown, some experimental results point to hMPCs. In hMPCs, DKK1 has a crucial role in proliferation and osteogenic differentiation [46], [47]. As shown in Fig. 5A, DKK1, but not DKK2, was expressed in primary hMPCs, H4-1 cells, UEET-12 cells and UET-13 cells. The expression of DKK2 protein was also confirmed in EFT whereas not in UET-13 cells (Fig. 5B). In EFT cell lines, by contrast, DKK2, but not DKK1, was expressed. We previously reported that the tetracycline-dependent expression of EWS/ETS confers EFT-like phenotypes in UET-13 cells [35]. Therefore, we tested the change of DKK gene expression using this model. As shown in Fig. 5C-F, both EWS/FLI1 and EWS/ERG expression resulted in a considerable increase in DKK2 gene expression. It is worth noting to describe that the expression level of the DKK1 gene was significantly decreased after EWS/ETS expression in UET-13 cells.
###end p 55
###begin title 56
The change in expression pattern of the DKK family with EWS/ETS's induction in UET-13 cells.
###end title 56
###begin p 57
###xml 177 182 <span type="species:ncbi:9606">human</span>
###xml 787 792 <span type="species:ncbi:9606">human</span>
A, The expression pattern of DKKs in hMPCs and EFT cells. DKK1 and DKK2 mRNAs in the H4-1, UEET-12, UET-13 and EFT cell lines were detected by RT-PCR. As an internal control, a human GAPDH gene was used. B, The expression of DKK2 protein in hMPCs and EFT cells. For the detection of secreted DKK2, cells were cultured for 48 hours and then the culture medium was analyzed by Western blotting. C, D, E, F, Relative level of DKK1 (C, D) and DKK2 (E, F) in UET-13 transfectants in the absence or presence of tetracycline. UET-13 transfectants were treated with or without 3 microg/ml of tetracycline for the indicated periods. Real-time RT-PCR was performed to investigate the expression pattern of the DKK family. Signal intensity was normalized using that of a control housekeeping gene (human GAPDH gene). Data are relative values with the SD for triplicate wells and normalized to the mRNA level at 0 hour which is arbitrarily set to 1.
###end p 57
###begin title 58
Mutually exclusive expression of DKK1 and DKK2 in SK-ES1 cells
###end title 58
###begin p 59
###xml 195 202 195 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g001">Fig. 1A</xref>
###xml 306 315 306 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g006">Fig. 6A&#8211;C</xref>
###xml 444 451 444 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g006">Fig. 6D</xref>
###xml 543 550 543 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g006">Fig. 6E</xref>
To further elucidate the biological roles of DKK genes in EFT cells, we introduced the DKK1 and DKK2 genes into the EFT cell line SK-ES1, in which the level of DKK2 expression is relatively low (Fig. 1A). Independent transfectants were confirmed to indeed express each gene by RT-PCR and Western blotting (Fig. 6A-C). Interestingly, when the DKK1 transfectants were examined by real-time PCR analysis, a reduction in DKK2 expression was found (Fig. 6D). In contrast, DKK2 overexpression induced a reduction in DKK1 expression in SK-ES1 cells (Fig. 6E). These results suggested that the expression of DKK1 and DKK2 related reciprocally in a mutually exclusive fashion in SK-ES1 cells.
###end p 59
###begin title 60
Mutually exclusive expression of DKK1 and DKK2 in SK-ES1 cells.
###end title 60
###begin p 61
###xml 292 297 <span type="species:ncbi:9606">human</span>
###xml 724 729 <span type="species:ncbi:9606">human</span>
A, B, Validation of DKK-V5 expression in SK-ES1 cells. The expression of DKK1-V5 and DKK2-V5 in SK-ES1 transfectants was observed by RT-PCR (A) and Western blot analysis (B). DEST#1, #2: SK-ES1-DEST#1, #2, DKK1#1, #2: SK-ES1-DKK1#1, #2, DKK2#1, #2: SK-ES1-DKK2#1, #2. As an internal control, human GAPDH (for RT-PCR) and beta-Actin (for Western blot) were used, respectively. C, Secretion of DKKs-V5 into cell culture supernatants. Secreted DKKs-V5 proteins were absorbed by TALON Metal Affinity Resin (Clontech) and analyzed by Western blotting, D, E, Relative level of DKK1 and DKK2 in SK-ES1 transfectants in SK-ES1-DKK1 (D) and SK-ES1-DKK2 (E). Signal intensity was normalized using that of a control housekeeping gene (human GAPDH gene). Data are relative values with the SD for triplicate wells and normalized to the mRNA level at DEST#1 which is arbitrarily set to 1.
###end p 61
###begin title 62
Expression of DKK1 inhibits the formation of subcutaneous tumors
###end title 62
###begin p 63
###xml 369 377 369 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004634-t001">Table. 1</xref>
###xml 379 386 379 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g007">Fig. 7A</xref>
###xml 619 629 619 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004634-g007">Fig. 7A, B</xref>
###xml 859 867 859 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004634-t001">Table. 1</xref>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
We next investigated the effect of DKK1 and DKK2 expression on tumorigenicity by subcutaneously implanting SK-ES1 transfectants into CB17/SCID mice. SK-ES1-DEST#1 and SK-ES1-DKK1#1 were implanted subcutaneously into CB17/SCID mice. The mice were sacrificed 28 days after injection. Four of the 10 mice injected with SK-ES1-DEST cells developed tumors (experiment #1 in Table. 1, Fig. 7A), in the case of SK-ES1-DKK1#1 cells, however, only one tumor mass was observed after similar preparation. In addition, the xenograft of DKK1-expressing SK-ES1 cells was significantly smaller than that of control SK-ES1-DEST cells (Fig. 7A, B). There were no morphological and pathological differences between xenografts formed by SK-ES1-DEST#1 and -DKK1#1 cells. Reproducible results were obtained by using another independent clone, SK-ES-DKK1#2 cells (experiment #2 in Table. 1). We also tested the tumorigenicity of SK-ES1-DKK2 cells in a similar manner. Although SK-ES1-DKK2#2 xenografts were significantly larger than control SK-ES1-DEST xenografts, the clone SK-ES1-DKK2#1 presented no significant difference from SK-ES1-DEST clones (data not shown).
###end p 63
###begin title 64
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
The effect of ectopic DKK1 expression on tumor cell growth in vivo.
###end title 64
###begin p 65
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
A, Examples of Immuno-deficient mice that have been injected with SK-ES1-DEST (DEST#1) and SK-ES1-DKK1 (DKK1#1) (left panels). The image was taken at 28 days after injection. Right panels indicate the xenografts of mice injected with DEST#1 and DKK1#1. Red circles indicate the positions of tumors. B, Tumor growth rates from mice injected with DEST#1 and DKK1#1. Diamond symbols indicate the tumor volume of mice injected with DEST#1; Box symbols indicate the tumor volume of mice injected with DKK1#1.
###end p 65
###begin title 66
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Formation of subcutaneous tumors in CB17/SCID mice by SK-ES1 cells.
###end title 66
###begin title 67
Discussion
###end title 67
###begin p 68
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Aguilera1">[16]</xref>
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Suzuki1">[48]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Suzuki2">[49]</xref>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Lee1">[50]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Niehrs1">[15]</xref>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Kuphal1">[17]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Sato1">[51]</xref>
In this study, we found that the expression of DKK2 was enhanced but that of DKK1 was suppressed in EFT cells. The suppression of DKK1 expression has been observed in several tumors [16], [48], [49], [50], and although elevated level of the DKK family occur in a number of tumor cells, most reports to date have been concerned with DKK1 and DKK3 [15]. In the case of DKK2, its suppression in tumors such as malignant melanoma [17] and gastrointestinal tumors [51] has been reported, but the elevated levels in cancer have not. Hence, the expression profile of the DKK family observed here is suggested to be specific to EFT.
###end p 68
###begin p 69
###xml 410 415 <span type="species:ncbi:9606">human</span>
We also demonstrated that the expression of DKK2 is regulated by the direct interaction of the chimeric protein EWS/ETS with EBS located in the promoter region of the gene. In contrast, although we also investigated the effect of EWS/ETS on DKK1 transcription, EWS/ETS exhibited no significant effect on DKK1 promoter activity as assessed by the reporter assay. However, the induction of EWS/ETS expression in human MPCs resulted in not only an increase in DKK2 gene expression but also a considerable decrease in DKK1 gene expression. Moreover, introduction of the DKK2 gene induced a reduction in DKK1 gene expression and vice versa in SK-ES1 cell. Taken together, our results indicate that EWS/ETS expression in EFT cells directly induces the up-regulation of DKK2 gene expression that consequently leads to a suppression of DKK1 expression, although the further analysis is required for understanding the underlying mechanism of EWS/ETS-mediated modulation of DKK family expression.
###end p 69
###begin p 70
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Mikheev2">[19]</xref>
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Mikheev3">[20]</xref>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Hsieh1">[24]</xref>
###xml 337 341 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Roth1">[52]</xref>
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Joesting1">[53]</xref>
###xml 555 562 555 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
Although DKK1 is known as a Wnt antagonist, the function of DKK2 is still controversial. Some studies indicated that DKK2 also acts as an antagonist of Wnt signaling, whereas others showed that DKK2 behaves rather agonistic to Wnt signaling. In some tumor types, Wnt antagonists including DKK1 act as tumor suppressors [19], [20], [24], [52], [53]. As we demonstrated in this study, ectopic expression of DKK1 in EFT cells resulted in the inhibition of tumor growth in SCID mice, whereas DKK2 expression did not and even possibly accelerated tumor growth in vivo, demonstrating that DKK2 does not act as a counterpart of DKK1. Therefore, our findings support reports that presented DKK2 has a distinct function from DKK1. As we described above, the up-regulation of DKK2 consequently leads to a suppression of DKK1 and thus possibly contributes to EFT phenotype indirectly by interfering with the suppressive function of DKK1 on tumor growth. To further investigate the role of DKK2 in EFT formation, we have tested the effect of temporal DKK2 knockdown by transient transfection with DKK2 siRNA, whereas no significant influence on cell growth and cell death was observed as assessed by MTT assay and Annexin V assay, respectively (data not shown). The further experiments to elucidate the direct effect of DKK2 on EFT phenotype are now underway.
###end p 70
###begin p 71
###xml 269 273 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Mikheev3">[20]</xref>
###xml 419 423 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Endo1">[54]</xref>
Interestingly, it was recently suggested that DKK1 also functions independently of the canonical Wnt/beta-catenin signaling pathway. For example, several studies have indicated that DKK1-mediated tumor suppression is independent of canonical Wnt/beta-catenin signaling [20]. It was also reported that Wnt3A-mediated activation of the canonical Wnt/beta-catenin signaling pathway induces neuritic outgrowth in EFT cells [54], and DKK1 mimics Wnt activity and induces neuritogenesis in EFT cells. Therefore, it is possible that DKK2 also has a function independent of Wnt signaling that is distinct from that of DKK1.
###end p 71
###begin p 72
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Horwitz1">[55]</xref>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Riggi1">[56]</xref>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-CastilleroTrejo1">[57]</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Miyagawa1">[35]</xref>
###xml 931 935 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004634-Tirode1">[58]</xref>
###xml 401 406 <span type="species:ncbi:9606">human</span>
As described above, DKK1 has a significant function in hMPCs and could stimulate cell proliferation while maintaining the undifferentiated phenotype [55]. Therefore, adequate DKK expression is essential for the maintenance of the MPC phenotype. Although the origins of EFT are still unclear, hMPCs are thought to be a candidate [56], [57] and we previously showed that inducible EWS/ETS expression in human MPCs confers EFT-like phenotypes [35]. Since, as we found in this study, EWS/ETS expression induces the down-regulation of DKK1 expression and up-regulation of DKK2 in UET-13 cells, an expression profile of the DKK family typical of EFT cells, it is reasonable to speculate that EWS/ETS-mediated change in the DKK family expression profile in hMPCs is involved in the development of EFT. Consistent with this, interestingly, a recent study revealed that the expression of DKK1 is up-regulated in EWS/FLI1-silenced EFT cells [58], in which feature of the mesenchymal progenitor including the capacity to differentiation into the osteogenic and adipogenic lineages are conferred. Considering the significance of DKK1 expression in hMPCs, EWS/ETS-mediated DKK1 suppression could impair the characteristics of hMPCs and contribute to their transformation into EFT.
###end p 72
###begin p 73
We are grateful to T. Motoyama for the NRS-1 cell line. We respectfully thank S. Yamauchi for her secretarial work.
###end p 73
###begin title 74
References
###end title 74
###begin article-title 75
Wnt pathway and breast cancer.
###end article-title 75
###begin article-title 76
The role of Wnt signaling in cancer and stem cells.
###end article-title 76
###begin article-title 77
Colorectal cancer and genetic alterations in the Wnt pathway.
###end article-title 77
###begin article-title 78
Wnt signaling and cancer.
###end article-title 78
###begin article-title 79
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
###end article-title 79
###begin article-title 80
Secreted antagonists of the Wnt signalling pathway.
###end article-title 80
###begin article-title 81
Wnt signalling: antagonistic Dickkopfs.
###end article-title 81
###begin article-title 82
Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins.
###end article-title 82
###begin article-title 83
LDL-receptor-related protein 6 is a receptor for Dickkopf proteins.
###end article-title 83
###begin article-title 84
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse.
###end article-title 84
###begin article-title 85
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Expression pattern of Dkk-1 during mouse limb development.
###end article-title 85
###begin article-title 86
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
En1 and Wnt7a interact with Dkk1 during limb development in the mouse.
###end article-title 86
###begin article-title 87
Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.
###end article-title 87
###begin article-title 88
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
###end article-title 88
###begin article-title 89
Function and biological roles of the Dickkopf family of Wnt modulators.
###end article-title 89
###begin article-title 90
###xml 73 78 <span type="species:ncbi:9606">human</span>
Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
###end article-title 90
###begin article-title 91
Expression of Dickkopf genes is strongly reduced in malignant melanoma.
###end article-title 91
###begin article-title 92
Dickkopf-1 activates cell death in MDA-MB435 melanoma cells.
###end article-title 92
###begin article-title 93
###xml 41 46 <span type="species:ncbi:9606">human</span>
Dickkopf-1 mediated tumor suppression in human breast carcinoma cells.
###end article-title 93
###begin article-title 94
A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.
###end article-title 94
###begin article-title 95
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.
###end article-title 95
###begin article-title 96
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors.
###end article-title 96
###begin article-title 97
Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model.
###end article-title 97
###begin article-title 98
Dickkopf-3/REIC functions as a suppressor gene of tumor growth.
###end article-title 98
###begin article-title 99
Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway.
###end article-title 99
###begin article-title 100
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines.
###end article-title 100
###begin article-title 101
Functional epigenomics identifies genes frequently silenced in prostate cancer.
###end article-title 101
###begin article-title 102
Ewing sarcoma family of tumors.
###end article-title 102
###begin article-title 103
Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma.
###end article-title 103
###begin article-title 104
Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells.
###end article-title 104
###begin article-title 105
EWS/ETS fusions activate telomerase in Ewing's tumors.
###end article-title 105
###begin article-title 106
Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein.
###end article-title 106
###begin article-title 107
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
###end article-title 107
###begin article-title 108
EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.
###end article-title 108
###begin article-title 109
###xml 98 103 <span type="species:ncbi:9606">human</span>
Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells.
###end article-title 109
###begin article-title 110
###xml 21 29 <span type="species:ncbi:7091">Silkworm</span>
Molecular Cloning of Silkworm Cdc37 and its Interaction with Hsp90 Chaperone.
###end article-title 110
###begin article-title 111
A monoclonal antibody specifically reactive with Ewing's sarcoma.
###end article-title 111
###begin article-title 112
[Cell line of small round cell tumor originating in the chest wall: W-ES].
###end article-title 112
###begin article-title 113
Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential.
###end article-title 113
###begin article-title 114
###xml 34 39 <span type="species:ncbi:9606">human</span>
Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines.
###end article-title 114
###begin article-title 115
###xml 45 50 <span type="species:ncbi:9606">human</span>
Characterization of N-myc amplification in a human neuroblastoma cell line by clones isolated following the phenol emulsion reassociation technique and by hexagonal field gel electrophoresis.
###end article-title 115
###begin article-title 116
###xml 20 25 <span type="species:ncbi:9606">human</span>
[Differentiation of human germ cell tumor cells].
###end article-title 116
###begin article-title 117
###xml 29 40 <span type="species:ncbi:7091">Bombyx mori</span>
Differential expression of a Bombyx mori AHA1 homologue during spermatogenesis.
###end article-title 117
###begin article-title 118
Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor.
###end article-title 118
###begin article-title 119
Biology of EWS/ETS fusions in Ewing's family tumors.
###end article-title 119
###begin article-title 120
Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow.
###end article-title 120
###begin article-title 121
###xml 86 91 <span type="species:ncbi:9606">human</span>
The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow.
###end article-title 121
###begin article-title 122
Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia.
###end article-title 122
###begin article-title 123
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer.
###end article-title 123
###begin article-title 124
Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines.
###end article-title 124
###begin article-title 125
###xml 61 66 <span type="species:ncbi:9606">human</span>
Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors.
###end article-title 125
###begin article-title 126
###xml 74 79 <span type="species:ncbi:9606">human</span>
Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells.
###end article-title 126
###begin article-title 127
Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
###end article-title 127
###begin article-title 128
Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism.
###end article-title 128
###begin article-title 129
Dkk-1-mediated expansion of adult stem cells.
###end article-title 129
###begin article-title 130
Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells.
###end article-title 130
###begin article-title 131
###xml 40 46 <span type="species:ncbi:10090">murine</span>
Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
###end article-title 131
###begin article-title 132
Mesenchymal stem cell features of Ewing tumors.
###end article-title 132
###begin p 133
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 133
###begin p 134
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 172 180 <span type="species:ncbi:9606">Children</span>
###xml 227 232 <span type="species:ncbi:9606">Human</span>
###xml 336 341 <span type="species:ncbi:9606">Child</span>
Funding: This work was supported in part by Health and Labour Sciences Research Grants (the 3rd term comprehensive 10-year-strategy for cancer control H19-010, Research on Children and Families H18-005 and H19-003, Research on Human Genome Tailor made and Research on Publicly Essential Drugs and Medical Devices H18-005) and Grant for Child Health and Development from the Ministry of Health, Labour and Welfare of Japan, JSPS. KAKENHI 18790263. This work was also supported by CREST, JST, a grant from the Japan Health Sciences Foundation for Research on Publicly Essential Drugs and Medical Devices and the Budget for Nuclear Research of the Ministry of Education, Culture, Sports, Science and Technology, based on the screening and counseling by the Atomic Energy Commission. Y. Miyagawa is an Awardee of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research (Japan) for the 3rd Term Comprehensive 10-Year-Strategy for Cancer Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 134

